AFP and liver disorder: Overall, 72 (86.7%) of all patients reviewed had at least one AFP measurement and 78 (93.9%) had at least one USS, of which 44 (56.4%) had at least one abnormal finding [diffuse increased echogenicity (53.8%) or evidence of portal hypertension (2.6%)].